ArticleFrontiers in immunology2026
The composition of MDSC-subpopulations PMN-like, M-like, and e-like MDSC is associated with the severity of infectious mononucleosis in pediatric patients.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Primary infection with the Epstein-Barr virus (EBV) in early childhood is often asymptomatic, whereas infection with EBV during adolescence or adulthood may lead to infectious mononucleosis (IM). Sometimes severe complications like hepatitis, spleen rupture, or myocarditis may appear during IM. Myeloid-derived suppressor cells (MDSC) are a heterogeneous group of regulatory immune cells with immunosuppressive activities. However, not much is known about the role of MDSC in IM. We assessed a clinical translational prospective study to examine the role of MDSC during the early and late phases of IM in pediatric patients. Method: We performed a longitudinal analysis of PMN-like, M-like, and e-like MDSC frequencies in 37 pediatric patients during the early (V1 < 28 days after symptom onset (T Results: We detected comparable frequencies of total MDSC-like cells during the course of IM (V1 median: 22.87%, V2 median: 16.10%, and V3 median: 16.58% of CD33+ cells, respectively). However, we observed temporal dynamics of the MDSC-like subpopulations PMN-like, M-like, and e-like MDSC during the early and late phases of IM. The frequency of PMN-like MDSC decreased significantly from V1 to V2 ( Conclusion: Our data highlights the rationale for in-depth analyses of MDSC subpopulations in further studies on IM and contributes to obtaining a more differentiated picture of the ongoing changes in MDSC-like cell distribution and the relationship between frequencies of MDSC-like cells and the complexity and severity of laboratory, clinical, and virological IM features.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.